displayed excellent anticancer activities against the HepG2/C3A line (25-50%). The potency of nano anticancer drugs was predicted by drug likeness using Lipinski's "rule of five". Taken together, compounds 11-23 could be used to treat cancers.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2018) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: